Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-019225
Filing Date
2013-03-27
Accepted
2013-03-27 20:17:00
Documents
1
Period of Report
2013-03-25

Document Format Files

Seq Description Document Type Size
1 DOUGLAS COLE FORM 4 rrd374457.html 4  
1 DOUGLAS COLE FORM 4 rrd374457.xml 4 3666
  Complete submission text file 0001181431-13-019225.txt   5064
Mailing Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472
Business Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472 617.715.3600
TETRAPHASE PHARMACEUTICALS INC (Issuer) CIK: 0001373707 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address AVEO PHARMACEUTICALS, INC. 75 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Cole Douglas G. (Reporting) CIK: 0001486373 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35837 | Film No.: 13721275